{{Rsnum
|rsid=12049671
|Gene=PTPRE
|Chromosome=10
|position=129737631
|Orientation=plus
|GMAF=0.185
|Gene_s=PTPRE
|Assembly=GRCh37.p5
|GenomeBuild=37.3
|dbSNPBuild=137
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}
{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 77.0 | 22.1 | 0.9
| HCB | 50.4 | 38.7 | 10.9
| JPT | 54.9 | 42.5 | 2.7
| YRI | 89.8 | 7.5 | 2.7
| ASW | 89.5 | 10.5 | 0.0
| CHB | 50.4 | 38.7 | 10.9
| CHD | 47.7 | 47.7 | 4.6
| GIH | 71.3 | 25.7 | 3.0
| LWK | 84.5 | 14.5 | 0.9
| MEX | 51.7 | 34.5 | 13.8
| MKK | 58.3 | 37.2 | 4.5
| TSI | 65.7 | 31.4 | 2.9
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=22952603
  |Trait=Response to amphetamines
  |Title=Genome-wide association study of d-amphetamine response in healthy volunteers identifies putative associations, including cadherin 13 (CDH13).
  |RiskAllele=
  |Pval=7E-6
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{on chip | Affy GenomeWide 6}}